Nutri Pharma has engaged

13.05.2004 - Nutri Pharma ASA has engaged Enskilda Securities to assist it in exploring and developing strategic alternatives.....

Oslo, May 13, 2004

Nutri Pharma ASA has engaged Enskilda Securities to assist it in exploring and developing strategic alternatives.

As previously announced Nutri Pharma is actively pursuing strategic opportunities in the areas of cholesterol reduction (functional foods and dietary supplements), weight management, soy protein and process technologies. Nutri Pharma has engaged Enskilda Securities to assist it in exploring, developing and pursuing strategic alternatives, which may include a possible sale of the whole or parts of the company or its business or assets. This process is expected to be concluded during 2004.


For further information please contact:
Eirik Uboe, CEO +47 23310880 or +44 7766 051466